IRadimed Corporation
IRMD
$94.94
-$2.26-2.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.42% | 23.18% | -8.93% | 1.93% | 3.03% |
| Total Depreciation and Amortization | 84.92% | 6.90% | -0.41% | -1.37% | -0.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.67% | -79.20% | 242.96% | -41.69% | 182.61% |
| Change in Net Operating Assets | -84.69% | 170.12% | -1,078.74% | -93.21% | 28.20% |
| Cash from Operations | -9.81% | 80.48% | -28.31% | -34.32% | 37.32% |
| Capital Expenditure | 56.84% | 28.72% | -32.52% | 26.77% | -235.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.03% | 14.47% | 17.55% | -32.31% | -48.71% |
| Cash from Investing | 55.25% | 27.92% | -28.15% | 23.80% | -215.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 69.17% | 17.45% | 78.56% | -2,947.75% | 72.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.05% | 0.00% | -13.69% | -0.04% | -0.05% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.90% | 0.89% | 5.78% | -26.02% | 2.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.48% | 240.04% | -471.03% | -83.90% | -6.53% |